Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PTAFR | P25105 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9458989 | 1.00 | GMNN (0.46) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459530 | 0.93 | GMNN (0.55) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459249 | 0.93 | GMNN (0.55) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459247 | 0.91 | GMNN (0.44) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459669 | 0.91 | GMNN (0.44) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459399 | 0.89 | GMNN (0.36) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459520 | 0.89 | GMNN (0.36) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459603 | 0.87 | GMNN (0.35) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459880 | 0.87 | GMNN (0.35) | GMNNUSP2LMNAPTAFRMTOR | |
| SCHEMBL9459928 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5234918-A | For cardiovascular, respiratory, carcinogenic and inflammatory disorders | AMERICAN CYANAMID COMPANY (US) | 1993-08-10 | — | — | US | disclosed |
| US-5215975-A | Certain hydroxy-phosphinyl-oxy-phenyl methyl-thiazolium hydroxide inner salts as PAF antagonists | AMERICAN CYANAMID COMPANY (US) | 1993-06-01 | — | — | US | disclosed |